- Posts: 12
- Thank you received: 3
1. You must be a registered website user in order to post and comment. Guests may read only.
2. Be kind and helpful, not rude and cynical.
3. Don't advertise or promote anything. You will be banned from the group.
4. Report problems to the moderators. THANK YOU!
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
www.sciencedirect.com/science/article/pii/S0248866315006293
Is there still a place for “old therapies” in the management of immune thrombocytopenia?
Conclusions
The use of new treatments such as RTX and TPO-RA in ITP has led to a major improvement in patient management. However, old molecules should not be forgotten and are still useful in specific conditions (Table 4), particularly because their efficacy and tolerance are well-known, and also because of their low cost. We thus suggest using dapsone as soon as possible in evolving ITP because of its safety and efficacy, which is assessed after 3–6 weeks. The prospective study being conducted in France will describe the efficacy of and tolerance to the molecule more precisely. When ineffective, and in ITP patients with positive ANA (> 1/160), hydroxychloroquine is an interesting alternative with a good response rate, which is often delayed (3 months), in half of the cases. Due to its virilizing effects and the potential risk of liver cancer, danazol will be used in elderly patients (> 65 years) only after ruling out prostate cancer or a previous history of thrombosis, and with a careful surveillance of liver enzymes. As the time to a response with hydroxychloroquine and danazol is long (around 2–3 months), a concomitant treatment should be transiently used particularly in patients with bleeding events or when the platelet count is below 20 G/L. Vinca-alkaloids can be used in patients who do not respond to IVIg or as an alternative treatment to IVIG before surgery, notably splenectomy. Vinblastine will be used preferentially because of its lower risk of neuropathy compared with vincristine, particularly in the elderly. However, the prolonged use of vinca-alkaloids is not recommended.
Table 4.
Treatment propositions.
Drugs Indications
Dapsone 2nd line therapy after corticosteroids
Rule out G6PD deficiency particularly in men
Non-splenectomized patients (less effective after splenectomy)
Not contraindicated during pregnancy
Danazol Patients>65years
Non-splenectomized or splenectomized patients
When thrombocytopenia due to myelodysplastic syndrome is not completely excluded
Hydroxychloroquine ITP secondary to lupus
Primary ITP with antinuclear antibodies (>1/160)
Not contraindicated during pregnancy and breastfeeding
Vinca-alkaloids Non-responders to IVIg and corticosteroids
To increase platelet count before splenectomy
G6PD: glucose-6-phosphate-deshydrogenase; ITP: immune thrombocytopenia; IVIg: intravenous immunoglobulins.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.
Please Log in or Create an account to join the conversation.

Platelet Disorder Support Association
8751 Brecksville Road Suite 150
Cleveland, OH 44141
440.746.9003 | pdsa@pdsa.org
The Platelet Disorder Support Association is a 501(c)3 organization and donations are tax deductible to the fullest extent allowed by law.
© Copyright 1997 - 2026, Platelet Disorder Support Association. All rights reserved.
IMPORTANT!
The Platelet Disorder Support Association does not provide medical advice or endorse any medication, vitamins or herbs. The information contained herein is not intended nor implied to be a substitute for professional medical advice and is provided for educational purposes only. Always seek the advice of your physician or other qualified healthcare provider before starting any new treatment, discontinuing an existing treatment and to discuss any questions you may have regarding your unique medical condition.